Form 4: Xometry COO Peter Goguen Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Peter Goguen, COO of Xometry, Inc., sold 986 shares of Class A Common Stock at an average price of $25.2014 on March 18, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- On March 18, 2025, Peter Goguen, the Chief Operating Officer of Xometry, Inc., sold 986 shares of Class A Common Stock.
- The sale was executed at a weighted average price of $25.2014 per share.
- The transactions occurred within a price range of $24.79 to $25.55.
- The sale was conducted under a Rule 10b5-1 trading plan adopted by Goguen at least 90 days prior to the transaction date.
- Following the transaction, Goguen directly owns 187,883 shares of Xometry's Class A Common Stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a routine stock sale under a pre-arranged trading plan. It doesn't inherently indicate positive or negative prospects for the company.
Industry Context
Insider sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on current, non-public information. Investors often monitor insider transactions for signals about a company's prospects, but sales under 10b5-1 plans are generally viewed as less informative.
Stakeholder Impact
- The sale of shares by a company executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 03/18/2025 | Date of the stock sale transaction. |
| 03/19/2025 | Date of signature by Attorney-in-Fact. |
Keywords
Xometry, Peter Goguen, insider trading, Form 4, stock sale, Rule 10b5-1, COO, XMTR
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.